Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy.

Human immunodeficiency virus type 1 (HIV-1)-infected CEM cells were treated by the HIV-1-specific inhibitors bis-heteroarylpiperazine (BHAP), 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1 H)-on e (TIBO) R82913, nevirapine, and the N3-methylthymine derivative of [2',5'-bis-O-(ter...

Полное описание

Библиографические подробности

Опубликовано в::	J Virol
Главные авторы:	Balzarini, J, Karlsson, A, Pérez-Pérez, M J, Camarasa, M J, Tarpley, W G, De Clercq, E
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology (ASM) 1993
Предметы:	Research Article
Online-ссылка:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC237935/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7688822/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.67.9.5353-5359.1993
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!